Literature DB >> 22939557

Regional treatment effects in studies of cardiorenal drugs: a summary of recent clinical trials.

John Lawrence, Steve Bai, H M James Hung, Robert O'Neill.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22939557     DOI： 10.1016/j.jacc.2012.04.051

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification.

Authors:  C Heneghan; C Blacklock; R Perera; R Davis; A Banerjee; P Gill; S Liew; L Chamas; J Hernandez; K Mahtani; G Hayward; S Harrison; D Lasserson; S Mickan; C Sellers; D Carnes; K Homer; L Steed; J Ross; N Denny; C Goyder; M Thompson; A Ward
Journal:  BMJ Open       Date:  2013-07-06       Impact factor: 2.692

2.  An assessment of randomized controlled trials (RCTs) for non-communicable diseases (NCDs): more and higher quality research is required in less developed countries.

Authors:  Hong Fan; Fujian Song
Journal:  Sci Rep       Date:  2015-08-14       Impact factor: 4.379

3.  Single-marker and multi-marker approaches to appraise the relationships between biomarkers and microalbuminuria in Chinese middle-aged and elderly from communities: a cross-sectional analysis.

Authors:  Shihui Fu; Yi Guo; Zhao Zhang; Leiming Luo; Ping Ye
Journal:  BMC Nephrol       Date:  2018-04-23       Impact factor: 2.388

4.  An assessment of factors associated with quality of randomized controlled trials for smoking cessation.

Authors:  Hong Fan; Fujian Song; Hai Gu; Jianming Wang; Guizhen Jia; Moyuan Lu; Jiao Qian; Lei Wang; Jiemiao Shen; Zhewen Ren
Journal:  Oncotarget       Date:  2016-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.